Yunnan Xitao Green Pharmaceutical

Yunnan Xitao Green Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and production of natural botanical medicines and Traditional Chinese Medicine (TCM). The company is particularly well-known for its focus on Erigeron breviscapus (Dengzhanhua) extracts, which are used to treat cardiovascular and cerebrovascular diseases. Its business model integrates the entire value chain from medicinal plant cultivation and extraction to the manufacturing of finished dosages such as injections, tablets, and capsules. Yunnan Xitao operates several GMP-certified production lines and maintains a significant presence in the domestic Chinese market for natural health products.